Poolbeg Pharma (POLB.L) traded up 1.35 % during a 24 hours period ending at 11:02 PM Central Europe on Tuesday 27th. One Poolbeg Pharma stock can currently be bought for about GBX 6.65 on popular exchanges. Current supply of Poolbeg Pharma stocks is 7.4 mn. Poolbeg Pharma has a current market capitalization of GBX 68 mn and approximately GBX 10.5 mn worth of Poolbeg Pharma was traded on exchanges in the last 24 hours. Since last month end, Poolbeg Pharma has traded -8.16 % down. Simple moving average of last 200 days is at GBX 6.08. The highest price of past 52 weeks was recorded at GBX 9.3 on 09/24/2026. 52 weeks low was at GBX 3.3 on 11/24/2025.
Here is how related stocks have performed in the past 24 hours:
Theworks (WRKS.L) traded up 1.05 % and now trades at GBX 96.4. Current market capitalisation for Theworks is GBX 80.3 mn. Current price/earnings ratio for Theworks is 11.57.
Kodal Minerals (KOD.L) traded flat 0 % and now trades at GBX 0.28. Current market capitalisation for Kodal Minerals is GBX 76.3 mn. Current price/earnings ratio for Kodal Minerals is 28.
Vast (VAST.L) traded flat 0 % and now trades at GBX 3.75. Current market capitalisation for Vast is GBX 80.7 mn.
Shield Therapeutics (STX.L) traded flat 0 % and now trades at GBX 5.45. Current market capitalisation for Shield Therapeutics is GBX 77.3 mn.
Akanda (AKAN) traded up 3.96 % and now trades at USD 1.09. Akanda has a market capitalisation of USD 793.5 k.
About Poolbeg Pharma
Poolbeg Pharma PLC is a clinical stage infectious disease pharmaceutical company based in London, UK. The company has set up a capital light clinical model, which aims to develop multiple products faster and more cost efficiently to meet the significant global medical need of treating and preventing infectious diseases.